NCT06892418Completed
Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study
A Clinical Study on the Effects of Ketoflex 12/3 Diet on Motor and Non-Motor Symptoms in Patients With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 2 Apr 2025
Brief summary (registry, in English)
This study aims to investigate the effects of the Ketoflex 12/3 diet on motor and non-motor symptoms in patients with Parkinson's disease. Participants will follow the Ketoflex 12/3 dietary regimen, and their cognitive function, motor symptoms, sleep patterns, gastrointestinal health, and overall well-being will be assessed through standardized clinical scales. The study will help determine whether a plant-based ketogenic diet combined with intermittent fasting can have a beneficial impact on Parkinson's disease progression.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 21 Mar 2025
- Start date
- 30 Mar 2024
- Primary completion date
- 30 Oct 2024
- Lead sponsor
- Istanbul Medipol University Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT06892418
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 30 Mar 2024 to the primary completion date, 30 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Severe vitamin deficiencies that have not been corrected prior to the study
Other illness
- History of alcohol or substance dependence
- Diagnosis of chronic renal failure
- Presence of neuromuscular disorders
- Having amalgam dental fillings and/or failure to remove them according to the SMART protocol
Who the study is looking for
- Diagnosed with Parkinson's disease
- Age between 40-85 years
- Native Turkish speakers
- Able to comply with the study protocol
Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul Medipol Universitesi Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.